Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study

<b>Background:</b> During the influenza A(H1N1) and COVID-19 pandemics, empirical antibiotic treatment (EAT) was widely administered to critically ill patients despite low rates of confirmed bacterial co-infection (COI). The clinical benefit of this practice remains uncertain and may con...

Full description

Saved in:
Bibliographic Details
Main Authors: Elisabeth Papiol, Julen Berrueta, Juan Carlos Ruíz-Rodríguez, Ricard Ferrer, Sara Manrique, Laura Claverias, Alejandro García-Martínez, Pau Orts, Emili Díaz, Rafael Zaragoza, Marco Marotta, María Bodí, Sandra Trefler, Josep Gómez, Ignacio Martín-Loeches, Alejandro Rodríguez
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/14/6/594
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849418259162464256
author Elisabeth Papiol
Julen Berrueta
Juan Carlos Ruíz-Rodríguez
Ricard Ferrer
Sara Manrique
Laura Claverias
Alejandro García-Martínez
Pau Orts
Emili Díaz
Rafael Zaragoza
Marco Marotta
María Bodí
Sandra Trefler
Josep Gómez
Ignacio Martín-Loeches
Alejandro Rodríguez
author_facet Elisabeth Papiol
Julen Berrueta
Juan Carlos Ruíz-Rodríguez
Ricard Ferrer
Sara Manrique
Laura Claverias
Alejandro García-Martínez
Pau Orts
Emili Díaz
Rafael Zaragoza
Marco Marotta
María Bodí
Sandra Trefler
Josep Gómez
Ignacio Martín-Loeches
Alejandro Rodríguez
author_sort Elisabeth Papiol
collection DOAJ
description <b>Background:</b> During the influenza A(H1N1) and COVID-19 pandemics, empirical antibiotic treatment (EAT) was widely administered to critically ill patients despite low rates of confirmed bacterial co-infection (COI). The clinical benefit of this practice remains uncertain and may contradict antimicrobial stewardship principles. <b>Objective:</b> To evaluate whether EAT at ICU admission reduces ventilator-associated pneumonia (VAP) incidence or ICU mortality in critically ill patients with pandemic viral pneumonia, stratified by presence of COI. <b>Methods:</b> This retrospective analysis combined two national multicentre ICU registries in Spain, including 4197 adult patients requiring invasive mechanical ventilation for influenza A(H1N1) or COVID-19 between 2009 and 2021. Primary outcomes were ICU mortality and VAP incidence. Analyses were stratified by microbiologically confirmed bacterial COI. Propensity score matching, Cox regression, General Linear (GLM), and random forest models were applied. <b>Results:</b> Among patients without COI (n = 3543), EAT was not associated with lower ICU mortality (OR = 1.02, 95%CI 0.81–1.28, <i>p</i> = 0.87) or VAP (OR = 1.02, 95%CI 0.79–1.39, <i>p</i> = 0.89). In patients with confirmed COI (n = 654), appropriate EAT was associated with reduced VAP (17.4% vs. 36.3%, <i>p</i> < 0.001) and ICU mortality (38.4% vs. 49.6%, OR = 1.89, 95%CI 1.13–3.14, <i>p</i> = 0.03) compared to inappropriate EAT. <b>Conclusions:</b> EAT was not associated with a lower incidence of VAP or higher survival rates and could be harmful if administered incorrectly. These findings support a more targeted approach to antibiotic use, guided by microbiology, biomarkers and stewardship principles.
format Article
id doaj-art-45e9c7e7b7c749e6837148c85bf30c97
institution Kabale University
issn 2079-6382
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj-art-45e9c7e7b7c749e6837148c85bf30c972025-08-20T03:32:28ZengMDPI AGAntibiotics2079-63822025-06-0114659410.3390/antibiotics14060594Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective StudyElisabeth Papiol0Julen Berrueta1Juan Carlos Ruíz-Rodríguez2Ricard Ferrer3Sara Manrique4Laura Claverias5Alejandro García-Martínez6Pau Orts7Emili Díaz8Rafael Zaragoza9Marco Marotta10María Bodí11Sandra Trefler12Josep Gómez13Ignacio Martín-Loeches14Alejandro Rodríguez15Intensive Care Department, Vall d’Hebron Universitary Hospital, 08035 Barcelona, SpainCritical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, SpainIntensive Care Department, Vall d’Hebron Universitary Hospital, 08035 Barcelona, SpainIntensive Care Department, Vall d’Hebron Universitary Hospital, 08035 Barcelona, SpainCritical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, SpainCritical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, SpainCritical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, SpainCritical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, SpainCritical Care Department, Hospital Parc Tauli, 08208 Sabadell, SpainCritical Care Department, Hospital Dr. Peset, 46017 Valencia, SpainCritical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, SpainCritical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, SpainCritical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, SpainTechnical Secretary Hospital Universitari Joan XXIII, 43005 Tarragona, SpainDepartment of Anaesthesia and Critical Care, Multidisciplinary Intensive Care Research Organization (MICRO), St James’s University Hospital, Trinity Centre for Health Sciences, D08 NHY5 Dublin, IrelandCritical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain<b>Background:</b> During the influenza A(H1N1) and COVID-19 pandemics, empirical antibiotic treatment (EAT) was widely administered to critically ill patients despite low rates of confirmed bacterial co-infection (COI). The clinical benefit of this practice remains uncertain and may contradict antimicrobial stewardship principles. <b>Objective:</b> To evaluate whether EAT at ICU admission reduces ventilator-associated pneumonia (VAP) incidence or ICU mortality in critically ill patients with pandemic viral pneumonia, stratified by presence of COI. <b>Methods:</b> This retrospective analysis combined two national multicentre ICU registries in Spain, including 4197 adult patients requiring invasive mechanical ventilation for influenza A(H1N1) or COVID-19 between 2009 and 2021. Primary outcomes were ICU mortality and VAP incidence. Analyses were stratified by microbiologically confirmed bacterial COI. Propensity score matching, Cox regression, General Linear (GLM), and random forest models were applied. <b>Results:</b> Among patients without COI (n = 3543), EAT was not associated with lower ICU mortality (OR = 1.02, 95%CI 0.81–1.28, <i>p</i> = 0.87) or VAP (OR = 1.02, 95%CI 0.79–1.39, <i>p</i> = 0.89). In patients with confirmed COI (n = 654), appropriate EAT was associated with reduced VAP (17.4% vs. 36.3%, <i>p</i> < 0.001) and ICU mortality (38.4% vs. 49.6%, OR = 1.89, 95%CI 1.13–3.14, <i>p</i> = 0.03) compared to inappropriate EAT. <b>Conclusions:</b> EAT was not associated with a lower incidence of VAP or higher survival rates and could be harmful if administered incorrectly. These findings support a more targeted approach to antibiotic use, guided by microbiology, biomarkers and stewardship principles.https://www.mdpi.com/2079-6382/14/6/594empirical antibiotic treatmentpandemic viral pneumoniaventilator-associated pneumoniaICU mortalityantimicrobial stewardship
spellingShingle Elisabeth Papiol
Julen Berrueta
Juan Carlos Ruíz-Rodríguez
Ricard Ferrer
Sara Manrique
Laura Claverias
Alejandro García-Martínez
Pau Orts
Emili Díaz
Rafael Zaragoza
Marco Marotta
María Bodí
Sandra Trefler
Josep Gómez
Ignacio Martín-Loeches
Alejandro Rodríguez
Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study
Antibiotics
empirical antibiotic treatment
pandemic viral pneumonia
ventilator-associated pneumonia
ICU mortality
antimicrobial stewardship
title Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study
title_full Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study
title_fullStr Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study
title_full_unstemmed Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study
title_short Does Empirical Antibiotic Use Improve Outcomes in Ventilated Patients with Pandemic Viral Infection? A Multicentre Retrospective Study
title_sort does empirical antibiotic use improve outcomes in ventilated patients with pandemic viral infection a multicentre retrospective study
topic empirical antibiotic treatment
pandemic viral pneumonia
ventilator-associated pneumonia
ICU mortality
antimicrobial stewardship
url https://www.mdpi.com/2079-6382/14/6/594
work_keys_str_mv AT elisabethpapiol doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT julenberrueta doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT juancarlosruizrodriguez doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT ricardferrer doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT saramanrique doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT lauraclaverias doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT alejandrogarciamartinez doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT pauorts doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT emilidiaz doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT rafaelzaragoza doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT marcomarotta doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT mariabodi doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT sandratrefler doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT josepgomez doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT ignaciomartinloeches doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy
AT alejandrorodriguez doesempiricalantibioticuseimproveoutcomesinventilatedpatientswithpandemicviralinfectionamulticentreretrospectivestudy